Características clínicas y pronóstico de pacientes con cáncer de mama HER2 positivo avanzado, en la era antes y después de terapias anti-HER2
Background: HER2+ breast cancer (BC) subtype overexpresses the Human Epidermal growth factor Receptor type-2 (HER2) and is characterized by its aggressiveness and its high sensitivity to monoclonal antibody-based HER2-targeted therapies. Aim: To assess the prognosis and evaluate the impact of novel...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Language: | Spanish / Castilian |
| Published: |
Sociedad Médica de Santiago
2018
|
| Subjects: | |
| Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001001095 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|